Lu Xiao-Yang, Huang Hong-Feng, Sheng-Tu Jian-Zhong, Liu Jian
Department of Clinical Pharmacology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
J Zhejiang Univ Sci B. 2005 Sep;6(9):885-91. doi: 10.1631/jzus.2005.B0885.
To assess the influence of cyclosporin A (CsA) and tacrolimus (FK506) on mycophenolic acid (MPA) and correlation analysis of the pharmacokinetic parameters and patient characteristics, clinical outcome in Chinese kidney transplant recipients, the pharmacokinetics of 1000 mg mycophenolate mofetil (MMF) twice daily was measured by high-performance liquid chromatography (HPLC). PKS (Pharmaceutical Kinetics Software) 1.0.2 software package was used for the calculation of pharmacokinetic parameters. The mean C(max), t(max), and AUC((0-12))were (21.88+/-10.52) microg/ml, (1.20+/-0.95) h, and (52.546+/-13.215) microg.h/ml, respectively. The level of AUC((0-12)) in the FK506 group was significantly higher than that in the CsA group. MPA appeared not to be affected by renal function. MPA AUC((0-12)) showed statistically significant difference according to the patient's gender.
为评估环孢素A(CsA)和他克莫司(FK506)对霉酚酸(MPA)的影响以及药代动力学参数与患者特征、中国肾移植受者临床结局的相关性分析,采用高效液相色谱法(HPLC)测定了每日两次服用1000 mg吗替麦考酚酯(MMF)的药代动力学。使用PKS(药物动力学软件)1.0.2软件包计算药代动力学参数。平均C(max)、t(max)和AUC((0 - 12))分别为(21.88±10.52)μg/ml、(1.20±0.95) h和(52.546±13.215)μg·h/ml。FK506组的AUC((0 - 12))水平显著高于CsA组。MPA似乎不受肾功能影响。MPA AUC((0 - 12))根据患者性别显示出统计学上的显著差异。